Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020
November 16, 2020 at 09:48 pm
Share
Remedent, Inc. announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced sales was USD 321,922 compared to USD 242,070 a year ago. Operating income was USD 61,313 compared to operating loss of USD 96,526 a year ago. Net income was USD 4,000 compared to net loss of USD 159,591 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 541,051 compared to USD 552,034 a year ago. Operating income was USD 71,817 compared to operating loss of USD 163,698 a year ago. Net income was USD 5,124 compared to net loss of USD 350,736 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.02 a year ago.
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
REMEDENT, INC. 
